Orchestrate the Interface between Health and Disease GPCRs arguably represent the most effective current therapeutic Given the tremendous success of GPCRs as therapeutic targets, considerable focus has been placed on the ability of these therapeutics to modulate diseases by acting at cell surface receptors.

and triterpenes isolated from Cryptostegia grandiflora against Candida auris FKBP12 Development and therapeutic Southwest Award Winner Monlunabant by Inversago Pharma for Metabolic Syndrome: Likelihood of Approval Tectonic Anti-Seizure Activity in Epilepsy Models Biophysicists decipher functionality of adrenaline-binding receptor Tectonic

Bryan Roth and Brian Krumm for their study on Molecular glues as potential GPCR therapeutics Drs. breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects GPR56: A potential therapeutic via site-selective activation of mTOR GPCR Binders, Drugs, and more Molecular glues as potential GPCR therapeutics $10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone Tectonic

Measuring and quantifying signaling bias reveals which candidates emphasize therapeutically beneficial Both assays provide unique profiles and a preferred receptor signaling bias for the therapeutics tested Once a favorable efficacy fingerprint is identified in therapeutic cells (through cell-based assays), Journal of Pharmacology and Experimental Therapeutics, 344 (3), 708–717. https://doi.org/10.1124/jpet Journal of Pharmacology and Experimental Therapeutics, 335 (3), 572–579. https://doi.org/10.1124/jpet

How do molecules make the leap from laboratory concept to therapeutic reality? miss the forest for the trees The critical importance of translation —turning lab data into meaningful therapeutic

diabetes to cancer, fibrosis, and CNS disorders — GPCRs  are at the heart of the world’s most pressing therapeutic Class in Drug Discovery GPCRs regulate countless physiological processes, making them a goldmine for therapeutic But the real  excitement is in what’s next: Biased signaling  for selective therapeutic effects. Orphan GPCRs  with untapped therapeutic potential. you’re in early discovery or clinical development, the strategies here could open doors in your own therapeutic

For innovators building tools, platforms, or therapeutics, these origin moments are where tomorrow’s receptors control localised signaling, how disease hijacks these systems, and how to target them for therapeutic Her work sits at the intersection of fundamental biology and therapeutic strategy. Knowing where  signals occur could unlock new therapeutic strategies, better efficacy, and fewer side

This foundational knowledge guides researchers in the development of new therapeutics. It can inform decisions in drug design, improving therapeutic outcomes and reducing unwanted side effects This understanding can enhance your appreciation for drug development and therapeutic action.

signaling, influencing a wide array of physiological processes and serving as critical targets for therapeutic significant findings that enhance our understanding of GPCRs' roles in immune function and potential therapeutic macrophages suggest that these GPCRs could be targeted to modulate inflammatory responses, offering potential therapeutic the field continues to evolve, the insights gained from this research will be instrumental in shaping therapeutic

and the complexity of the central nervous system (CNS) pose a challenge for developing successful therapeutics Emerging GPCR Therapeutic Targets in CNS Drug Discovery GPCRs have been studied for decades, but there Of the traditional GPCRs, CBRs are gaining ground as potential therapeutic targets in several CNS diseases One of the best tools to study therapeutic targets are fluorescent ligands , which are very useful in G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative

Ligands designed to activate therapeutically beneficial pathways, while avoiding those associated with The therapeutic logic is sound: if signaling pathways are separable, they are potentially selectable. Family C), adhesion GPCRs, and Frizzled receptors (Family VI) have all attracted growing interest as new therapeutic both been implicated in COVID-19 pathophysiology — and represent active targets for receptor-directed therapeutic provides the needed mechanistic depth to define the functional selectivity  that may ultimately determine therapeutic

portfolio of more than 2,750 assays, and one of the broadest ranges of GPCR targets in the industry, across therapeutic sharing our science, our services, and our team's expertise with researchers advancing GPCR-targeted therapeutics

Selection  – Master GPCR behavior beyond second messengers   Build sharper strategies for GPCR-targeted therapeutics receptor biology—and how they’re being used to de-orphanize GPCRs, explore autoantibodies, and uncover new therapeutic

mGluR2, and a big headline, Novo Nordisk’s $2.2B deal with Septerna to develop GPCR-targeted obesity therapeutics Biased signalling of Class B G protein-coupled receptor-targeted therapeutics .  

Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Christopher Langmead and colleagues' work on the 5-HT2C receptor as a therapeutic target for substance GPCR Symposium on ''GPCRs as Therapeutic Modalities' Share your project with a 1-minute abstract video Protein and Exendin-P5 Biased Agonist Molecular and structural insights into the 5-HT2C receptor as a therapeutic teams up with addiction treatment maker Indivior to make digital therapeutics for substance use disorders

the cell depends on the ligand–receptor complex — and that distinction has direct implications for therapeutic Recycling Versus Degradation: The CCR5 Example The therapeutic stakes of this distinction are illustrated logic, the mechanistic distinctions, and the interpretive frameworks that connect trafficking data to therapeutic

Celtarys’ cutting-edge fluorescent ligand technology and accelerate the development of GPCR-targeted therapeutics accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology into therapeutic

November 7th : Drug Disposition in Physiological Tissues as a Therapeutic Variable. December 5th : Unique Exploitable GPCR-Ligand Behaviors for Therapeutic Benefit. Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with SEP-786, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism Confo Therapeutics a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety OMass Therapeutics

This approach reveals: Hidden target overlap New therapeutic hypotheses “Off-target” effects that may This reroutes discovery toward: Functionally selective ligands Better therapeutic windows More predictable What matters now is not the category , but the fit: Does the chemical matter support the therapeutic

This week's highlights: Kudos to our partner, GPCR Therapeutics, for partnering with Bridge Biotherapeutics acids conjugation with [Cp*Rh(H2O)3]2+ by using the meta-dynamics/FMO3 approach Industry News GPCR Therapeutics - Providing the next generation of high-impact medicines Structure Therapeutics Provides Comprehensive Study Neurocrine opening two Phase 1 trials in oral Parkinson’s therapies Bearing Fruit: Deep Apple Therapeutics Launches to Screen AI-Generated Virtual Libraries AbbVie to Acquire Cerevel Therapeutics in Transformative

Whether you're decoding signaling pathways or designing the next generation of therapeutics, Revvity includes over 1,000 functional assays representing more than 550 GPCR and other targets, trusted by therapeutic

not just the pancreas This tool helped clarify: Which neurons respond Which cell populations drive therapeutic metabolic therapy Guide how next-generation incretin drugs are designed Support cell-targeted conjugate therapeutic

That choice determines whether you risk over- or under-dosing, miss safety windows, or miss therapeutic More nuanced control, fewer off-target liabilities, and novel therapeutic windows. Correctly distinguishing these mechanisms helps refine therapeutic index calculations, prioritize safer

Xavier Leroy on his appointment as CEO of GIO Therapeutics! Congratulations to Domain Therapeutics for being awarded the RHU SPRINT consortium grant. Endocrinology, and Taste The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Living Cells with Cucurbit[7]uril and Hemicyanine as a "Turn-On" Fluorescence Probe Industry News Domain Therapeutics Xavier Leroy appointed as CEO of GIO Therapeutics GPCR Events, Meetings, and Webinars NOW!

GPCRs are one of the most important families of therapeutic targets in the pharmaceutical industry molecular binding mechanism behind C5a and C5aR interaction is crucial for developing novel immunological therapeutics fluorescent probes have proven to be optimal tools to perform fluorescence-based assays to unlock the therapeutic Function, Structure and Therapeutic Potential of Complement C5a Receptors.

Advances in biased signaling, allosterism, and endosomal signaling have opened new therapeutic frontiers

👉 Join Terry’s Corner, your essential launchpad into the world of therapeutic science Unlock "The History

Discovery on Target’s 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled Receptors for New Therapeutic Industry News MBX aims for $136M IPO to take potential rival to Ascendis' Yorvipath into phase 3 Certa Therapeutics proteins for biology and health research Innovate UK announced the winners of its Transforming Cancer Therapeutics

delivers cutting-edge imaging and analysis that accelerates the discovery of new and life-changing therapeutics comprehensive approach enables Axxam to support clients worldwide in identifying and optimizing new therapeutic

through: Why certain disease architectures require multi-target engagement in the first place, and the therapeutic across GLP-1, GIP, and glucagon receptor types The two-edged character of multi-target engagement: why therapeutic